Today’s pulse
This cycle's signal is a single mechanism wearing seven masks. A May 22 mini-review maps how microplastics and nanoplastics drive mitochondrial ROS, regulated cell death, and immune exhaustion — the exposome speaking directly to the mitochondrion — while a parallel human study shows the same particles remodeling the gut holobiont. Read together, they are a near-textbook rendering of the Cell Danger Response (CDR), the stuck-defense state that ties exposomics, mitochondrial bioenergetics, and the gut-immune system into one loop.
Pillar 1 — Clinical Metabolomics
A 12-metabolite blood panel flags liver injury in women before standard tests do
Researchers used NMR-based metabolomics plus ELISA to build a targeted 12-metabolite serum panel as a liquid biopsy for early hepatocellular injury in females with MetALD (metabolic-and-alcohol-associated liver disease), published in the International Journal of Molecular Sciences on May 22, 2026. The panel was designed to catch injury and progression at a stage where conventional liver enzymes still read as unremarkable. This is the diagnostic-gateway pillar turning a small-molecule signature into an early, sex-specific readout rather than waiting for frank organ damage.
Why it matters for optimization: Measuring a metabolite signature lets us compare against optimal — not survival — ranges and intervene while the network is still correctable.
International Journal of Molecular Sciences (MDPI), May 22, 2026 →Pillar 2 — Evolutionary Medicine
The anabolic/catabolic seesaw, reframed as the engine of age-related disease
A life-history review in Evolution, Medicine, and Public Health (Oxford) integrates the hyperfunction theory of aging with evolutionary mismatch, arguing that chronic disease emerges from an imbalanced axis of growth-and-proliferation (anabolic) versus maintenance-and-dormancy (catabolic) signaling, governed by IGF-1, mTOR, AMPK, and Klotho. It situates the modern epidemic of non-communicable disease as the predictable output of bodies tuned for scarcity now living in caloric and sedentary surplus. The piece is a recent synthesis rather than a 7-day-fresh trial, included as the strongest current articulation of the mismatch lens.
Why it matters for optimization: It gives a mechanistic vocabulary — mTOR up, AMPK down — for the network-wide range-shifting we are trying to rebalance, not suppress.
Evolution, Medicine, and Public Health (Oxford Academic), vol 13:111, 2025 →Pillar 3 — Chronobiology
Putting a clock on the prescription pad
A translational review in npj Biological Timing and Sleep (May 2, 2026) by Elizabeth Klerman argues that adding time-of-day and time-of-year information to diagnosis, treatment, and prevention is a low-cost, high-yield change to clinical practice — but one that requires new methods, training, and regulatory action to implement. The core claim is that chronobiology has matured scientifically since 2000 and the bottleneck is now translation, not discovery. As the environmental-timekeeper pillar, it reframes timing itself as a modifiable variable: when a measurement is taken or a dose is given can change the result as much as what is given.
Why it matters for optimization: Optimal ranges are themselves time-stamped; a cortisol or glucose value is only interpretable against the hour it was drawn.
npj Biological Timing and Sleep (Nature), May 2, 2026 →Pillar 4 — Exposomics
Microplastics as a multi-pathway cell-death trigger
A mini-review in Frontiers in Public Health (May 22, 2026) systematizes how micro- and nanoplastics, once internalized by endocytosis, generate excess reactive oxygen species, drive organelle stress and genotoxicity, and ignite a cascade of regulated cell-death modalities — apoptosis, ferroptosis, pyroptosis, and autophagy — that progresses from chronic immune activation to immune exhaustion and remodels the tissue microenvironment toward cancer susceptibility. Nanoplastics' ability to cross biological barriers and form biocoronas alters their biological identity and host-cell interactions. Crucially, the first domino is mitochondrial.
Why it matters for optimization: It locates a ubiquitous, measurable exposure at the head of the same ROS-and-cell-death cascade we are trying to keep cells out of.
Frontiers in Public Health, May 22, 2026 →Pillar 5 — Mitochondrial Bioenergetics
Restoring mitophagy improves both halves of the cardiac cycle
Work published in iScience on the postbiotic and mitophagy activator urolithin A reports cardioprotection and enhanced mitochondrial quality preclinically, alongside improved human cardiovascular biomarkers including reduced plasma ceramides after supplementation in older adults. Urolithin A improved both diastolic and systolic function in aging and heart-failure models, whereas NAD+-precursor approaches like NMN improved systolic dysfunction alone. This is the energy-engine pillar illustrating mitohormesis-adjacent repair: clearing damaged mitochondria rather than merely flogging output. The finding is from early 2025 and is included as the strongest current mitophagy signal connecting to the cycle's exposome theme.
Why it matters for optimization: If exposome insults open the ROS/cell-death cascade at the mitochondrion, mitophagy activation is a bioidentical-adjacent lever to close it.
iScience (Cell Press), 2025 →Pillar 6 — Gut-Immune System
Plastic particles measurably remodel the human gut community
A human study in Gut Microbes (2026) reports gut microbiome remodeling induced by microplastic exposure, converging with systematic-review evidence that microplastics impair short-chain-fatty-acid production, alter mitochondrial homeostasis and ROS signaling, and shift the community toward dysbiosis and chronic inflammation. The same butyrate axis is the target of a 140-patient randomized, placebo-controlled IBD trial of microencapsulated sodium butyrate, which enriched SCFA-producing taxa (Lachnospiraceae in ulcerative colitis, Butyricicoccus in Crohn's) and supported remission maintenance. Together they show the internal ecosystem as both victim of and lever against the exposome.
Why it matters for optimization: Butyrate sits at the intersection of barrier integrity, immune tone, and mitochondrial fuel — a probiotic/phytoceutical-tier handle before any xenobiotic.
Gut Microbes (Taylor & Francis), 2026 →Pillar 7 — Epigenetics
The pace-of-aging clock keeps winning predictive head-to-heads
Recent analyses continue to position DunedinPACE — a third-generation methylation clock reading the rate of biological aging across 173 CpG sites — as the most consistent epigenetic predictor among biomarkers tested, outperforming simple clinical measures for all-cause mortality and showing the strongest, most consistent associations with cognitive decline in older adults (medRxiv, March 2026; summarized via Fight Aging!, March 2026). Companion cohort work shows smoking, higher BMI, elevated glucose, and poor blood-pressure profiles accelerate the clock, while physical activity and better diet slow it. This is the dynamic-gene-regulator pillar made actionable: a rate, not a fixed age, that responds to inputs.
Why it matters for optimization: DunedinPACE turns 'is this working?' into a measurable, intervention-responsive number rather than a hopeful narrative.
Fight Aging! / medRxiv, March 2026 →The through-line
One network, seven angles
Exposomics, mitochondrial bioenergetics, and the gut-immune system are three views of one cascade: particle internalization drives mitochondrial ROS, then regulated cell death and immune exhaustion, while the same particles degrade SCFA production and microbial balance with mitochondrial homeostasis in the loop. That arc — an environmental signal trapping the mitochondrion in a defensive, low-output state that won't resolve — is the Cell Danger Response, the unifying mechanism HOMe places beneath chronic disease.
Practitioner’s move
What to do today
For any patient with an unexplained inflammatory or fatigue pattern, treat exposome load as a measurable upstream variable, not background noise: pair a metabolomic/biomarker readout (ceramides, SCFA status) with concrete plastic-exposure reduction, and use a mitophagy- and butyrate-supporting strategy to help cells exit the CDR loop — verifying, where feasible, with a pace-of-aging clock over time rather than by symptoms alone.